NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Drug Use Investigation of COMIRNATY Intramuscular Injection

CompletedN/A

Sponsor: Pfizer

Conditions: COVID-19

Interventions: BNT162b2

Countries: Japan

Post-marketing study, Chotor study of COMIRNATY vaccenees followed for 11months. Serious adverse events and COVID-19 observed during the follow-up period will be collected, and the long-term safety of this product will be assessed.

Eligibility overview

Sex: ALL

Age: 16 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Subjects who have participated in the Investigation of Health Status of Recipients Vaccinated First and have provided written consent to continue participation in this study.

Exclusion Criteria:

* No exclusion criteria.

Locations (1)

Tokyo, Japan